Mapping interruptions 

in the genome to unlock 

future therapies

Broken String Biosciences is a genomics company with the goal of advancing therapeutic discovery and development by assessing the stability of the genome. 

To unlock new medicines, knowledge of how they interrupt our genetic code is essential. 

These breaks in our DNA can have important positive and negative consequences to our health.  

Precision mapping of genomic breaks, provides insights that will enable the development of novel therapies.

We are developing a platform of sequencing tools to enable the safe and sustainable development of the next generation of innovative medicines, including cell and gene therapies.

 

Leadership team

Felix Dobbs

CEO

  • LinkedIn

Prof Simon Reed

CSO

  • LinkedIn

Simon Kerr

Chair & COO

  • LinkedIn

Dr Patrick van Eijk

CTO

  • LinkedIn

Subscribe for updates

  • LinkedIn
  • Twitter

© 2021 by Broken String Biosciences Ltd. 

Salisbury House

Station Rd

Cambridge CB1 2LA

United Kingdom